Ravi Maharjan | Pharmaceutics | Best Researcher Award

Published on by Academic Achievements

Dr. Ravi Maharjan | Pharmaceutics | Best Researcher Award

Dr. Ravi Maharjan | Pharmaceutics | Assistant Research Professor at Yonsei University | South Korea

Pharmaceutics is the foundation of Dr. Ravi Maharjan’s distinguished career as a research professor at Yonsei University, Korea, where he has been at the forefront of integrating AI/ML and Digital Twin technologies to revolutionize biopharmaceutical manufacturing, particularly in mRNA and siRNA-based lipid nanoparticle (LNP) vaccine development. Dr. Ravi Maharjan earned his PhD in Pharmaceutics and has since developed a deep expertise in biopharmaceutical process optimization, continuous manufacturing, lyophilization, stabilization strategies, and innovative delivery approaches targeting ocular and brain tissues. His professional experience spans extensive teaching, mentoring, and research leadership roles, where he has guided national and international collaborations with universities, pharmaceutical companies, and research institutions, including Pusan National University, CHA University, RCPE, RNAAnalytics Austria, and IMDEA Spain, demonstrating his ability to bridge academic research with industrial applications. Dr. Ravi Maharjan’s research interests focus on applying AI/ML algorithms for predictive modeling of complex pharmaceutical processes, optimizing formulations, ensuring protein stability, and enhancing the physical and biological stability of therapeutics. His work integrates pharmaceutics, process analytical technologies (PAT), quality by design (QbD), experimental design (DOE), and computational modeling to advance next-generation biopharmaceutical platforms. Among his key research skills are data-driven formulation design, predictive modeling, digital twin deployment, computational optimization of LNP delivery, lyophilized formulation screening, molecular simulation, process monitoring, and the translation of lab-scale research into continuous manufacturing systems. Dr. Ravi Maharjan has an impressive record of scholarly contributions, including over 23 SCIE Q1 publications, two books, two book chapters, more than 115 peer-review assignments, over 30 conference presentations, and eight invited talks. He has served as associate editor for Pharmaceutical Science and Technology (USA), editorial board member for Scientific Reports (Nature Portfolio, UK), Pharmaceutics (Switzerland), and Current Pharmaceutical Biotechnology (UAE), as well as conference organizer for multiple international events. His awards and honors recognize his contributions to both fundamental pharmaceutics and applied biopharmaceutical manufacturing, highlighting his excellence in research innovation and mentorship. Dr. Ravi Maharjan has demonstrated outstanding ability to secure funding, lead interdisciplinary projects, and foster scientific collaboration across countries and institutions, contributing to the advancement of mRNA and siRNA therapeutics, the optimization of excipients, and the improvement of drug delivery systems. His work on digital twins and AI/ML-driven process optimization has paved the way for predictive control in continuous manufacturing, ensuring reproducibility, efficiency, and quality in pharmaceutical production. In conclusion, Dr. Ravi Maharjan embodies the integration of scientific innovation, computational methods, and practical pharmaceutics expertise, making significant impacts in biopharmaceutical sciences, while continuing to mentor the next generation of researchers, drive technological innovation, and advance knowledge in AI-assisted pharmaceutical development.

Profile: Google Scholar

Featured Publications 

  1. Tripathi, J., Thapa, P., Maharjan, R., & Jeong, S. H. (2019). Current state and future perspectives on gastroretentive drug delivery systems. Citations: 246
  2. Maharjan, R., Hada, S., Lee, J. E., Han, H. K., Kim, K. H., Seo, H. J., Foged, C., … (2023). Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. Citations: 48
  3. Maharjan, R., Kim, K. H., Lee, K., Han, H. K., & Jeong, S. H. (2024). Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches. Citations: 44
  4. Maharjan, R., & Jeong, S. H. (2020). High shear seeded granulation: Its preparation mechanism, formulation, process, evaluation, and mathematical simulation. Citations: 37
  5. Bhujel, R., Maharjan, R., Kim, N. A., & Jeong, S. H. (2021). Practical quality attributes of polymeric microparticles with current understanding and future perspectives. Citations: 29
  6. Maharjan, R., Lee, J. C., Lee, K., Han, H. K., Kim, K. H., & Jeong, S. H. (2023). Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry. Citations: 28
  7. Kim, K. H., Lee, J. E., Lee, J. C., Maharjan, R., Oh, H., Lee, K., Kim, N. A., & Jeong, S. H. (2023). Optimization of HPLCCAD method for simultaneous analysis of different lipids in lipid nanoparticles with analytical QbD. Citations: 17

 

Eni Bushi | Pharmaceutical | Best Review Paper Award-7740

Published on by Academic Achievements

Dr. Eni Bushi | Pharmaceutical | Best Review Paper Award

Dr. Eni Bushi | Pharmaceutical – PhD student at University of Medicine Tirana, Albania

Eni Bushi (Beçi) is a dynamic pharmaceutical professional and researcher whose work bridges academia and the pharmaceutical industry. With extensive experience in pharmaceutical technology, quality assurance, and public health, she has made significant contributions both as a researcher and a leader in pharmaceutical practice. As the current Head of the Quality Assurance Department at Profarma sh.a. and a faculty member at the University of Medicine in Tirana, she plays a crucial role in shaping drug development standards and mentoring emerging professionals. A member of key scientific bodies such as NanoAlb and the Academy of Pharmacy “Eureka,” she exemplifies a strong commitment to advancing pharmaceutical knowledge through rigorous scientific inquiry and industry innovation.

Profile Verified

Scopus

Education

Eni Bushi holds a Master of Science in Pharmaceutical Sciences from the University of Medicine, Tirana, where she graduated with a perfect GPA and defended a thesis focused on prescription practices among elderly patients. Demonstrating her multidisciplinary outlook, she pursued a Master of Business Administration (MBA) at the University of New York Tirana, concentrating on healthcare management, with a thesis on Lean implementation in health systems. Currently, she is a PhD candidate in Pharmaceutical Technology at the same university, focusing on innovative semisolid formulations and their stability. Her academic journey has been enhanced by international certifications and professional development courses in nanotechnology, analytical validation, and Good Laboratory Practices.

Experience

Professionally, Eni Bushi has cultivated a strong career trajectory from community pharmacy to pharmaceutical manufacturing and research. Starting as a community pharmacist, she developed early experience in patient care and medication management. She then transitioned to Profarma sh.a., where she rose from Specialist to Head of the Quality Assurance Department, leading regulatory compliance, validation processes, and interdepartmental coordination. Simultaneously, she has served as a laboratory assistant and research mentor at the University of Medicine in Tirana. Her industry-academic hybrid role enables her to influence both pharmaceutical practice and education, while also fostering research innovation in drug development and regulatory science.

Research Interest

Eni Bushi’s research interests center on pharmaceutical technology, quality systems, antimicrobial resistance, and health systems improvement. Her current doctoral research focuses on semisolid drug formulations, with an emphasis on their physicochemical stability and comparative efficacy. She is particularly interested in integrating nanotechnology into drug delivery systems, and has pursued specialized training in nanomedicine. Her previous studies have explored the knowledge and behavior surrounding antibiotic use, as well as Lean strategies in healthcare environments. These interdisciplinary themes reflect her goal of advancing public health outcomes through innovation in drug formulation and pharmaceutical services.

Awards

Throughout her academic and professional journey, Eni Bushi has received recognition for her academic excellence and leadership. She was awarded the “Excellent Student” distinction by the University of Tirana’s Rectorate and has been consistently invited to contribute to international forums and scientific conferences. Her nomination for the Best Review Paper Award is underpinned by a record of impactful publications, academic mentorship, and a leadership role in pharmaceutical quality assurance.

Selected Publications

  1. 📘 Evaluation of the Knowledge, Attitude and Public Awareness about the Use of Antibiotic and Antibiotic Resistance in Albania (2024) – Indian Journal of Pharmaceutical Education and Research. Cited by 6 articles.
  2. 🧴 Formulation, Preparation and Evaluation of a Natural Cosmetic Product (2023) – Albanian Journal of Medical and Health Sciences. Cited by 3 articles.
  3. 🏥 Using Expert Consensus to Evaluate the Readiness Factors of Lean Implementation in Healthcare (2022) – International Journal of Scientific Research and Management. Cited by 9 articles.
  4. 👵 Prevalence and Factors Associated with Potentially Inappropriate Prescriptions among Older Patients at Hospital Discharge in Albania (2016) – Journal of Evaluation in Clinical Practice. Cited by 28 articles.
  5. 🧪 Theoretical Aspects of the Application of “Quality by Design” Approach in Drug Formulation (2025, Thesis Supervision) – Unpublished.
  6. 💊 Prevalence Assessment and Analysis of Self-Reported Use of Stimulant and Sedative Drugs among University Students (2023, Thesis Supervision) – University of Medicine, Tirana.
  7. 🧬 Analysis on the Level of Knowledge, Attitude, and Public Awareness Towards the Use of Antibiotics and Antimicrobial Resistance (2021, Thesis Supervision) – University of Medicine, Tirana.

Conclusion

Eni Bushi demonstrates a strong and evolving profile as a researcher, practitioner, and academic leader in the field of pharmaceutical sciences. Her combined background in pharmacy, business management, and pharmaceutical technology positions her uniquely to contribute to transformative change in drug formulation, health policy, and quality assurance. Her dedication to innovation, public health, and regulatory science makes her a highly deserving candidate for the Best Review Paper Award. Her work not only exemplifies academic excellence but also provides practical value to both the pharmaceutical industry and healthcare systems in Albania and beyond.